An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease. (2023)
Attributed to:
A novel vaccine for broad protection against meningococcal disease: progression to phase I clinical trial
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.ade3901
PubMed Identifier: 37343082
Publication URI: http://europepmc.org/abstract/MED/37343082
Type: Journal Article/Review
Volume: 15
Parent Publication: Science translational medicine
Issue: 701
ISSN: 1946-6234